Chemed Reports Q3 Adjusted Earnings Per Share $4.86.

CHEMED REPORTS THIRD-QUARTER 2020 RESULTS.
Q3 ADJUSTED EARNINGS PER SHARE $4.86.
Q3 GAAP EARNINGS PER SHARE $4.14.
Q3 REVENUE $528 MILLION VERSUS REFINITIV IBES ESTIMATE OF $514.2 MILLION.
SEES FY 2020 ADJUSTED EARNINGS PER SHARE $18.00 TO $18.15 EXCLUDING ITEMS.Q3 EARNINGS PER SHARE ESTIMATE $3.97 -- REFINITIV IBES DATA.
QTRLY REVENUE INCREASED 9.9% TO $528 MILLION.
QTRLY ADJUSTED DILUTED EPS OF $4.86.
ROTO-ROOTER IS FORECASTED TO ACHIEVE FULL-YEAR 2020 REVENUE GROWTH OF 12.5% TO 13.0%.
QTRLY VITAS NET PATIENT REVENUE OF $337 MILLION, AN INCREASE OF 4.8%.
QTRLY ROTO-ROOTER REVENUE OF $191 MILLION, AN INCREASE OF 20.4%.